Semaglutide in New Orleans — Physician-Supervised Weight Loss
FDA-approved Semaglutide (same molecule as Wegovy and Ozempic) for New Orleans residents, prescribed and monitored by licensed clinicians at our Metairie clinic. Cash-pay program that bypasses the insurance prior-auth maze.
Why New Orleans Chooses Aspire for Semaglutide
Getting Semaglutide in New Orleans through traditional insurance has become a months-long battle of prior authorizations, BMI gatekeeping, and pharmacy backorders. Aspire's cash-pay medical weight loss program removes those obstacles — licensed clinicians, consistent supply, and monthly follow-up without the insurance games.
Average 1–2 lbs/week
Clinically observed pace during dose titration.
Physician-supervised
Monthly check-ins, lab monitoring, and dose adjustments.
FDA-approved
Semaglutide is FDA-approved for weight loss (Wegovy) and diabetes (Ozempic).
Once-weekly injection
Administered at home with easy-to-use prefilled pens or syringes.
Cardiovascular benefits
Clinical trials show reduced cardiovascular events in at-risk patients.
No insurance games
Cash-pay program avoids prior-auth delays and BMI gatekeeping.
What to Expect
- 01
Initial consultation (30 min)
Full medical history, weight-loss goals, and baseline labs. Physician confirms Semaglutide is appropriate for you and rules out contraindications.
- 02
First prescription + starter dose
Begin at 0.25 mg once weekly — the lowest dose to minimize GI side effects while your body adjusts.
- 03
Monthly dose titration
Gradual increase (0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg) over approximately 4–5 months to maximum tolerated dose.
- 04
Ongoing monitoring
Monthly check-ins for weight, labs (as needed), side effect management, and dose adjustments.
- 05
Maintenance phase
Once you reach your goal weight, shift to a lower maintenance dose to sustain losses. Most patients stay on maintenance for 1–2 years.
New Orleans Access
Aspire's clinic is at 3445 North Causeway Blvd, Suite 900 in Metairie — 10–20 minutes from every New Orleans neighborhood via I-10 or the Causeway.
Semaglutide New Orleans — FAQ
What is Semaglutide?
A GLP-1 receptor agonist FDA-approved for weight loss (Wegovy) and type 2 diabetes (Ozempic). Slows digestion, reduces appetite, improves glucose control.
Do I need insurance?
No — Aspire's program is cash-pay. This avoids the prior-auth and BMI gatekeeping that have made Semaglutide hard to obtain through insurance.
How much weight will I lose?
Clinical averages are 10–15% of body weight over 6–12 months. Individual results vary by dose, diet, activity, and metabolism.
Tirzepatide vs. Semaglutide?
Tirzepatide (Mounjaro/Zepbound) has shown ~20% body-weight loss vs. ~15% for Semaglutide in head-to-head trials. Both are available at Aspire — physician recommends based on your history.
Semaglutide Weight Loss
Start Semaglutide in New Orleans
Same-week consultations available. Cash-pay — no insurance required.